These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31449780)

  • 21. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey.
    Niederwieser D; Baldomero H; Szer J; Gratwohl M; Aljurf M; Atsuta Y; Bouzas LF; Confer D; Greinix H; Horowitz M; Iida M; Lipton J; Mohty M; Novitzky N; Nunez J; Passweg J; Pasquini MC; Kodera Y; Apperley J; Seber A; Gratwohl A
    Bone Marrow Transplant; 2016 Jun; 51(6):778-85. PubMed ID: 26901703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost and quality issues in establishing hematopoietic cell transplant program in developing countries.
    Hashmi SK; Srivastava A; Rasheed W; Adil S; Wu T; Jagasia M; Nassar A; Hwang WYK; Hamidieh AA; Greinix HT; Pasquini MC; Apperley JF; Aljurf M
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):167-172. PubMed ID: 28732192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.
    Aljurf M; Weisdorf D; Hashmi S; Nassar A; Gluckman E; Mohty M; Rizzo D; Pasquini M; Hamadani M; Saber W; Hari P; Kharfan-Dabaja M; Majhail N; Gerges U; Hamidieh AA; Hussain F; Elhaddad A; Mahmoud HK; Tbakhi A; Othman TB; Hamladji RM; Bekadja MA; Ahmed P; Bazarbachi A; Adil S; Alkindi S; Ladeb S; Dennison D; Patel M; Lu P; Quessar AE; Okamoto S; Atsuta Y; Alhejazi A; Ayas MF; Ahmed SO; Novitzky N; Srivastava A; Seber A; Solh HE; Ghavamzadeh A; Confer D; Kodera Y; Hildegard G; Szer J; Horowitz MM; Niederwieser D
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2330-2337. PubMed ID: 31002990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic engraftment and graft failure after bone marrow transplantation.
    Quinones RR
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):3-17. PubMed ID: 8095382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association.
    Bitan M; van Walraven SM; Worel N; Ball LM; Styczynski J; Torrabadella M; Witt V; Shaw BE; Seber A; Yabe H; Greinix HT; Peters C; Gluckman E; Rocha V; Halter J; Pulsipher MA
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):96-103. PubMed ID: 26307344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic stem cell transplantation activity in Europe 1999.
    Gratwohl A; Passweg J; Baldomero H; Urbano-Ispizua A;
    Bone Marrow Transplant; 2001 May; 27(9):899-916. PubMed ID: 11436100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study.
    Cowan AJ; Baldomero H; Atsuta Y; Mikhael J; Aljurf M; Seber A; Greinix H; Koh M; Worel N; Libby EN; Pasquini M; Galeano S; Saber W; Iida M; Jaimovich G; Rolon JM; Kodera Y; Benakli M; Nosa BG; Elhaddad A; Szer J; Passweg J; Kroeger N; Weisdorf D; Niederwieser D
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2372-2377. PubMed ID: 32846200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forging international collaboration and alliances to establish the largest transplant center in the north of Vietnam.
    Khanh BQ; Binh VTT; Thanh NH; Huong DPT; Thuy DT; Ha NK; Childs RW
    Semin Hematol; 2023 Sep; 60(4):243-250. PubMed ID: 37723024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
    Tomblyn MR; Ewell M; Bredeson C; Kahl BS; Goodman SA; Horowitz MM; Vose JM; Negrin RS; Laport GG
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1051-7. PubMed ID: 21073974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indications for bone marrow and peripheral stem cell transplantation in malignant hematological diseases].
    Gratwohl A
    Ther Umsch; 1996 Feb; 53(2):152-7. PubMed ID: 8629266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
    Watt SM; Austin E; Armitage S
    Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
    Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
    Biol Blood Marrow Transplant; 2017 May; 23(5):726-735. PubMed ID: 28115275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework Analysis.
    Andrick B; Tusing L; Jones LK; Hu Y; Sneidman R; Gregor C; Basu S; Lynch JP; Vadakara J
    Transplant Cell Ther; 2022 Jun; 28(6):334.e1-334.e9. PubMed ID: 35189400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J; Baldomero H
    Bone Marrow Transplant; 1997 Mar; 19(5):407-19. PubMed ID: 9052905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant Population.
    Barth D; Singleton M; Monohan G; McClune B; Adams V
    Cell Transplant; 2022; 31():9636897221080385. PubMed ID: 35225031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?
    Atkins HL; Muraro PA; van Laar JM; Pavletic SZ
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S177-83. PubMed ID: 22226104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
    Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
    J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.
    Passweg JR; Baldomero H; Ansari M; Baerlocher GM; Bargetzi M; Chalandon Y; Duchosal MA; Gerull S; Güngör T; Halter JP; Heim D; Hess U; Leibundgut K; Masouridi-Levrat S; Müller A; Nair G; Pabst T; Renner C; Schmidt A; Stussi G; Nicoloso de Faveri G; Schanz U; For The Swiss Blood Stem Cell Transplantation Group Sbst
    Swiss Med Wkly; 2018; 148():w14589. PubMed ID: 29493715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.